Pascal Soriot (AstraZeneca)

Pascal Soriot is the CEO of AstraZeneca, a major global pharmaceutical company known for developing vaccines and medicines. He became CEO in 2012 and has overseen the company’s growth and innovation, especially in oncology and respiratory treatments. Under his leadership, AstraZeneca played a prominent role in developing a COVID-19 vaccine in collaboration with the University of Oxford. Soriot's emphasis on research and strategic partnerships has significantly advanced the company’s position in the pharmaceutical industry, focusing on bringing new therapies to market while navigating the complexities of global health challenges.